Practitioners urged to consider whether telehealth may be an appropriate alternative for patients during the ongoing fuel crisis  Telehealth consultations could help patients maintain access to healthcare amid calls to conserve fuel, the Australian …

The latest on GLP-1 listings, NSW broadens nasal FluMist access and a potential pharmacy payment for diphtheria vaccination were among our readers’ picks this week A pricing agreement is needed …

Several individuals from both pharmacy and retail have climbed the AFR Rich List  The founders of Chemist Warehouse have continued to see their wealth rise in the past 12 months, …

MM2026 Scholarships are now open… And the call for abstracts for AdPha’s upcoming conference are closing soon, the organisation says Opportunities are again available for pharmacists to attend and showcase …

Manufacturer confirms plans to phase out its Benpen injection products from November 2026  Commercial reasons are behind Seqirus’s decision to discontinue its Benpen (benzylpenicillin sodium) injectable antibiotic products, the Therapeutic Goods Administration (TGA) reports.   The regulator confirmed …

One leading pharmacist outlines why the 2026 federal Budget was such a disappointment, as a new position statement highlights the importance of MBS access “At a broad level, the Budget …

AdPha has created a new platform for mentoring and networking, developed exclusively for pharmacy professionals Advanced Pharmacy Australia (AdPha) has today (Friday 29 May 2026) officially launched AdPha Connect, a …

Three Verrocchis have eclipsed media mogul Kerry Stokes’ wealth to land inside the top 10 on the AFR Rich List Chemist Warehouse (CWH) co-founder Mario Verrocchi and brothers Adrian and …

Large study using loyalty card logs shows more than one in four customers who purchased menstrual items also bought a pain product People who menstruate were four times more likely …

While business experts are urging pharmacy owners to focus on core product ranges, the message in May 1936 was somewhat different  Writing in the Australasian Journal of Pharmacy, Western Australian pharmacy owner D Mendelawitz, …

The latest in medicines news from MIMS New products Elacestrant (dihydrochloride) (Orserdu) is an orally active estrogen receptor (ER)‑α antagonist and degrader. Elacestrant inhibits the estradiol-dependent and independent growth of ERα‑positive breast …

Grants program gives next-generation pharmacists an opportunity to connect with experience  All three winners of the 2026 PDL Student Grant Program will attend the Pharmaceutical Society of Australia (PSA) national …